Our findings align with previous research indicating that IGF1 signaling governs mitochondrial dynamics and turnover in cancer cells through the NRF2‐BNIP3 pathway (Riis et al. 2020; Lyons et al. 2017). This evidence concerns the gene IGF1 and cancer.